Literature DB >> 3276253

Decision analysis for isoniazid preventive therapy: take it or leave it?

D E Snider.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3276253     DOI： 10.1164/ajrccm/137.1.2

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN： 0003-0805


× No keyword cloud information.
  4 in total

1.  Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons.

Authors:  Timothy R Sterling; Nigel A Scott; Jose M Miro; Guilherme Calvet; Alberto La Rosa; Rosa Infante; Michael P Chen; Debra A Benator; Fred Gordin; Constance A Benson; Richard E Chaisson; M Elsa Villarino
Journal:  AIDS       Date:  2016-06-19       Impact factor: 4.177

2.  Tuberculosis prevention practices and perspectives of physicians in DeKalb County, GA.

Authors:  M M Braun; P J Wiesner
Journal:  Public Health Rep       Date:  1994 Mar-Apr       Impact factor: 2.792

3.  Preventive medicine for HIV-infected patients: an analysis of isoniazid prophylaxis for tuberculin reactors and for anergic patients.

Authors:  D N Rose; C B Schechter; H S Sacks
Journal:  J Gen Intern Med       Date:  1992 Nov-Dec       Impact factor: 5.128

Review 4.  Tuberculosis in the 1990s. Issues for primary care physicians.

Authors:  J M Fitzgerald
Journal:  Can Fam Physician       Date:  1995-06       Impact factor: 3.275
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.